Yes it is i always thought it was part of us, google

New Post Public Reply Private Reply Replies (3) Message Board
toodles wrenchman #50572
1,102
Yes it is i always thought it was part of us, google healthra.net or healthra.org its us totally. Also check this one out https://www.healthra.org/resources/hosting-vi...ring-2021/

Health Research Alliance
About
Members
Working Groups
Issues
Events
HRA Platforms
Resources
Newsletters
NFRI
Jobs
RESOURCES
Hosting Virtual Events [HRA Members Meeting, Virtual, Spring 2021]
Recording of the session
Arne Bakker slide deck
Jenni Danai slide deck
Nicole Burpo slide deck
Christina (Leah) Kline slide deck
Hosting Virtual Events - Resources
Lung Cancer Initiative video (mentioned in Jenni's presentation)
Zoom hints (mentioned in Nicole's presentation)
As we all have experienced, 2020 was the year of hosting virtual events. Have you spent hours researching the how-to’s of managing virtual meetings? This session will discuss the nuts and bolts of organizing and facilitating online events and will showcase studies of best practices in hosting your event. Dr. Arne Bakker will highlight what has worked well, how to encourage a culture of open communication and meaningful participation with your audience, and how to select the most appropriate platform for your event. In addition to Dr. Bakker, a panel of HRA members will share stories of how they have incorporated virtual tools into other areas of grantmaking such as conducting virtual board meetings, site visits, as well as connecting with grantees, and advisors.

Moderators
Shandra Koler
Senior Program Officer | The Sontag Foundation

Shandra Koler joined the Sontag Foundation in 2014. The Sontag Foundation is one of the largest funders of brain cancer related research in North America. The Foundation was established in 2002 by Frederick and Susan Sontag following Susan’s successful battle with a normally lethal form of brain cancer. To date the Foundation has granted $38 million to 55 scientists at 39 major academic medical and research centers in the United States and Canada. Shandra oversees and manages the Foundation’s grant portfolio. Shandra joined the Foundation with 16+ years of public service focusing on creating strategic community alliances, operations administration, project implementation and oversight. Her career started in municipal government in Cleveland, Ohio, initiating and sustaining collaborative partnerships and designing and implementing safety-net programs for animal care services. She received several service awards, including the Mayor’s Outstanding Community Member Award. Shandra expanded her civil service work by serving as program director for a neighborhood leadership development program, an initiative of the Mandel Foundation and as a community development specialist for a federal economic recovery initiative.

Jessica Biddinger
Senior Manager, Pre-Award and Operational Guidelines Oversight | American Heart Association

Jessica is a Senior Manager in Research Operations at the American Heart Association. In this role, she manages the applications and peer review teams and supports both AHA’s foundational and strategic research programs. Prior to joining the AHA, Jessica worked at Johns Hopkins School of Medicine and School of Nursing with core responsibilities including program development, grant submission, pre- and post-award activities, tracking and reporting, evaluation, and business development. She also has prior non-profit experience working with the American Urological Association. Jessica earned a BS in Chemistry from the University of Vermont and an MS in Biotechnology from Johns Hopkins University.

Presenter
Arne Bakker, PhD
Director, Meetings and Community for Science | The Chan Zuckerberg Initiative

Arne Bakker is the Director of Meetings and Community for Science at the Chan Zuckerberg Initiative. He has a PhD in tumor immunology from the Netherlands Cancer Institute and did his postdoctoral research at UC Berkeley. Before joining the Chan Zuckerberg Initiative, Arne was Assistant Dean of Career Education for PhDs and Postdocs at Stanford University where he helped graduate students and postdocs find meaningful work. Throughout his career, Arne has always been actively bringing scientists together: he ran a Science Festival in Amsterdam, co-organized PhD career conferences at UC Berkeley and Stanford, and hosted several events at the Bay Area Science Festival. Now at CZI, Arne leads the team that organizes 15-20 scientific meetings a year for the researchers and communities that CZI funds and supports. In addition, he partners with the various CZI program teams to build and support collaborative communities, using the lessons he has learned during his multifaceted career.

Member Speakers
Jenni Danai, MPH
Senior Director of Programs | Lung Cancer Initiative of North Carolina

Jenni Danai is the Senior Director of Programs for the Lung Cancer Initiative where she oversees and provides direction on survivorship, education, research and access programs. Jenni has been instrumental in developing and growing these programs since she started with LCI in 2013. She assembled lung cancer research experts in North Carolina for LCI’s first internal Scientific Advisory Committee. From there, she established review committees including an external committee made up of experts from across the country. Jenni constructed LCI’s research funding mechanisms starting with the Research Fellows program in 2015, then the Vicky Amidon Innovation Grant in Lung Cancer Research in 2018 and most recent the Career Development award in 2019. Through her leadership the research program and other LCI’s programs have grown and evolved impacting the lives of more lung cancer patients every year. Before working at LCI, Jenni was the Health Initiatives Manager for the North Carolina Academy of Family Physicians where she managed grant-funded projects for several public health issues including health disparities, childhood obesity and tobacco. In her role, she collaborated directly with primary care providers to provide education and resources for them to better meet the needs of their patients. She continues many of these collaborations at LCI with a new focus of education and awareness around lung cancer. Jenni serves on the Duke Cancer Institute’s Community Advisory Council and the Early Detection Subcommittee for the North Carolina Advisory Committee on Cancer Coordination and Control. Jenni received her Master’s in Public Health Education from UNC-Greensboro, her Bachelors of Community Health at the University of Illinois and she completed a Health Disparities Fellowship with the Duke Global Health Institute.

Nicole Burpo, MS
Research Operations Manager | American Heart Association

Nicole Burpo is Operations Manager in Strategic Research at the American Heart Association, where she oversees several of the largest awards offered by AHA. The awards her team manages represent more than $200M in research funding, focusing on specific areas of cardiovascular disease research, such as atrial fibrillation, brain health and cognition, nicotine and vaping addiction, and COVID-19.

Prior to joining AHA, Nicole held a variety of roles, including monitoring legacy nuclear waste, examining reclaimed coal mine sites, and researching biofilm formations.

Nicole’s love of the biological world coupled with her degree in genetics enabled her to study the flora and fauna in remarkable places such as the Texas desert, rainforests of Mexico, and cave systems in Borneo. She is passionate about healthcare equity and nutrition security and is currently wrapping up her MPH at UNC Gillings School of Global Public Health.

Christina (Leah) Kline, PhD
Assistant Director, Scientific Reviews and Grants Administration | AACR

C. Leah Kline joined the American Association for Cancer Research in 2017. The AACR has awarded more than $480 million in grants to more than 800 scientists for research projects that aim to advance the understanding and treatment of cancer. In her current role, as part of the Scientific Review and Grants Administration department at AACR, she is focused on managing many of the grants that are funded by Stand Up To Cancer; the AACR is the Scientific Partner of Stand Up To Cancer. Leah has 25+ years of professional experience ranging from laboratory research to grants administration/management, not only in cancer but also in microbiology and diabetic retinopathy. She received her PhD at Pennsylvania State University, and pursued postdoctoral training under the mentorship of physician-scientist Wafik El-Deiry, MD, PhD at Penn State Cancer Institute, and subsequently, Fox Chas





TOODLES

Univec Conglomerate Inc (UNVC) Stock Research Links

UNVC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 9

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 4

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 3

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 5

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 6

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 3

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 4

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Soleno Therapeutics Celebrates FDA Approval of VYKAT XR for PWS

Updated Category News Views 420

Soleno Therapeutics Announces FDA Approval for VYKAT XR Soleno Therapeutics, Inc. (NASDAQ: SLNO), a notable biopharmaceutical company, has made a significant announcement regarding the U.S. Food and Drug Administration (FDA) approval of VYKAT XR (diazoxide choline) extended-release tablets. This new treatment targets hyperphagia in individuals aged four and older...

Continue Reading
aTyr Pharma Faces Legal Challenges: Investors Urged to Act

Updated Category News Views 173

aTyr Pharma's Legal Situation and Its Implications Recent developments surrounding aTyr Pharma, Inc. (NASDAQ: ATYR) have caught the attention of investors, particularly as the company faces significant legal challenges. The situation arose from a steep decline in share value triggered by disappointing results from a key clinical trial. This decline, marked by an...

Continue Reading
Primo Brands Boosts Share Repurchase Program by $50 Million

Updated Category News Views 145

Primo Brands Boosts Share Repurchase Program Primo Brands Corporation (NYSE: PRMB) is excited to announce a significant increase in its share repurchase program. This decision, made by the Board of Directors, involves raising the repurchase authorization by $50 million, bringing the total program authorization to an impressive $300 million. This enhancement in the share...

Continue Reading
GOTRAX Partners with RSMG Select to Inspire Youth Movement

Updated Category News Views 83

GOTRAX Teams Up with RSMG Select for Youth Development GOTRAX has embarked on an inspiring journey through its partnership with RSMG Select, aimed at nurturing not just young athletes but the community at large. The collaboration has transformed the experience for youth participating in futsal, allowing for significant growth and empowerment beyond the typical sports...

Continue Reading
Zenas BioPharma Celebrates Major Milestones in Q3 2025

Updated Category News Views 245

Zenas BioPharma Celebrates Major Milestones in Q3 2025 - Obexelimab Phase 3 INDIGO trial topline results in Immunoglobulin G4-Related Disease (IgG4-RD) expected around year-end. - Reported highly positive 12-week primary endpoint results from Phase 2 MoonStone trial of obexelimab in Relapsing MS (RMS). - Secured development and commercialization rights for three...

Continue Reading